10 Jun 2021
by Ankur Srivastava, Paul Thomas, Nathan WP Cantley, Talal Valliani, Fraser Todd, Alka Joshi

Service evaluation of a primary care pathway utilising non-invasive biochemical tests to risk-stratify significant fibrosis in patients with Non-Alcoholic Fatty Liver Disease (NAFLD)

Nathan Cantley, Fraser Todd, Alka Joshi, Paul Thomas, Talal Valliani, Ankur Srivastava

Related topics

Authors

Ankur Srivastava

Nhs North Bristol Trust

Paul Thomas

Consultant Clinical Scientist, Severn Pathology, Southmead Hospital, Bristol

Nathan WP Cantley

Nhs North Bristol Trust

Talal Valliani

Nhs North Bristol Trust

Fraser Todd

Nhs North Bristol Trust

Alka Joshi

Nhs North Bristol Trust